ABXL vs IDXX · rev $235.2M vs P/E 40, rev $2.36B
ABXL (ABXL) versus IDEXX Laboratories Inc (IDXX) — a side-by-side from cached financials, not a winner call.
ABXL (ABXL) common stock listed on NYSE.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Latest reported ABXL revenue for 2025-12-31 was $235.2M. Net income was $36.5M. Revenue was up 110.2% from 2024-12-31 to 2025-12-31. ABXL currently screens at market cap $0.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
ABXL currently screens at market cap $0. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Not investment advice. Open the ABXL and IDXX stock pages for the full models.
Not investment advice.